SCHEMBL17629950

SCHEMBL17629950

CCOCCCc1cc(C#N)ccc1-c1ccc(-n2ccnc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.48
PDE1A P54750 1/20 0.48
PDE1B Q01064 1/20 0.48
PDE3B Q13370 1/20 0.48
PDE1C Q14123 1/20 0.48
PDE3A Q14432 1/20 0.48
CYP2D6 P10635 9/20 0.45
CYP3A4 P08684 8/20 0.45
CYP2C9 P11712 7/20 0.45
CYP1A2 P05177 5/20 0.45
CYP2C19 P33261 5/20 0.45
CYP19A1 P11511 3/20 0.45
ADH5 P11766 6/20 0.42
LMNA P02545 1/20 0.39
MAPK1 P28482 1/20 0.39
ALOX15 P16050 2/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
MEN1 O00255 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17642945 0.87 PDE3B (0.50) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17629984 0.85 PDE2A (0.50) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17643466 0.84 PDE2A (0.49) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17643465 0.82 ADH5 (0.50) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17643462 0.80 ADH5 (0.52) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17630085 0.80 PDE3B (0.48) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17629958 0.80 PDE2A (0.48) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17630063 0.79 ADH5 (0.46) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17630146 0.79 PDE2A (0.47) PDE2APDE1APDE1BPDE3BPDE1C
SCHEMBL17630007 0.78 HRH2 (0.36) PDE3ACYP19A1LMNACYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016046782-A1 IMIDAZOLE BIARYL COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2016-03-31 WO disclosed